Patent · US Active

Hepatitis C virus inhibitors

US8957203B2 · kind B2 · utility

2Cited by

13References

3Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Sheldon Hiebert · Steinbach, CA
Ramkumar Rajamani · Wallingford, US
Li-Qiang Sun · Foster City, US
Eric Mull · Guilford, US
Eric P. Gillis · Cheshire, US
Michael S. Bowsher · Prospect, US
Qian Zhao · Louisville, US
Nicholas A. Meanwell · East Hampton, US
Kishore V. Renduchintala · Hyderabad, IN
Kandhasamy Sarkunam · Hosur, IN
Pulicharla Nagalakshmi · Bengaluru, IN
P. V. K. Suresh Babu · Bengaluru, IN
Paul Michael Scola · Glastonbury, US

Key dates

Filing date	Apr 30, 2012
Grant date	Feb 17, 2015
Priority date	—
Expiry date	Jun 6, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Hepatitis C virus inhibitors having the general formula (I)are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.